Please assess the completion status of the following clinical trial:

Trial Title: Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic Chronic heart failure (NYHA II, III or IV)~* Left ventricular systolic dysfunction (LVEF ≤ 35%)~* Sinus rhythm and resting heart rate ≥ 70 bpm~* Optimal and unchanged CHF medications or dosages~Exclusion Criteria:~* Unstable condition within previous 4 weeks~* Myocardial infarction or coronary revascularisation within previous 2 months~* Stroke or transient cerebral ischaemia within previous 4 weeks~* Congenital heart disease~* Severe valvular disease~* Active myocarditis~* Permanent atrial fibrillation or flutter

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ivabradine (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).